Across TCGA pan-cancer cohorts, GAPDHP36 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of GAPDHP36’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where GAPDHP36 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types GAPDHP36 is over-expressed in tumor.

COAD and LUSC are the cancer types where GAPDHP36 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GAPDHP36 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	All	+0.048	.037	2	view →
LUSC	All	II,III,IV	+0.014	.040	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: GAPDHP36 RNA expression & survival · all GAPDHP36 data types